KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Common Equity (2016 - 2025)

Clorox (CLX) has 17 years of Common Equity data on record, last reported at $35.0 million in Q4 2025.

  • For Q4 2025, Common Equity fell 71.07% year-over-year to $35.0 million; the TTM value through Dec 2025 reached $35.0 million, down 71.07%, while the annual FY2025 figure was $321.0 million, 34.76% down from the prior year.
  • Common Equity reached $35.0 million in Q4 2025 per CLX's latest filing, down from $138.0 million in the prior quarter.
  • Across five years, Common Equity topped out at $938.0 million in Q1 2021 and bottomed at $35.0 million in Q4 2025.
  • Average Common Equity over 5 years is $377.2 million, with a median of $354.5 million recorded in 2023.
  • Peak YoY movement for Common Equity: crashed 73.59% in 2023, then soared 70.99% in 2024.
  • A 5-year view of Common Equity shows it stood at $491.0 million in 2021, then changed by 0.0% to $491.0 million in 2022, then crashed by 55.6% to $218.0 million in 2023, then plummeted by 44.5% to $121.0 million in 2024, then plummeted by 71.07% to $35.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $35.0 million in Q4 2025, $138.0 million in Q3 2025, and $321.0 million in Q2 2025.